7.2 C
New York
Friday, December 3, 2021
spot_img

“If you have had COVID-19, please do not get vaccinated”

#COVID19 #infection #recovered #immunity #vaccinated #FDA

“If you have had COVID-19, please do not get vaccinated” — Dr. Hooman Noorchashm, MD, PhD, a cardiac surgeon and patient advocate, has warned the FDA that “clear and present danger” exists for those who have had COVID-19 and subsequently get vaccinated.

Evidence from Washington University School of Medicine shows long-lasting immunity to COVID-19 exists in those who have had and recovered from the natural infection

At both 7 months and 11 months after infection, most of the participants had bone marrow plasma cells (BMPCs) that secreted antibodies specific for the spike protein encoded by SARS-CoV-2

The BMPCs were found in amounts similar to those found in people who had been vaccinated against tetanus or diphtheria, which are considered to provide long-lasting immunity

The antibody protection gained in those who’ve recovered from COVID-19 is likely to continue “indefinitely

Vaccination may be more dangerous for those who’ve had COVID-19, as the immune response reactivated by the COVID-19 vaccine may trigger inflammation in tissues where the viral antigens are present

The benefits of experimental COVID-19 vaccination may not outweigh the risks, especially if 1 has already had COVID-19.

Have a healthy, prosperous week, Keep the Faith!

Paul Ebeling
Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he is the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.   

Related Articles

Stay Connected

15,334FansLike
43,300FollowersFollow
2,855SubscribersSubscribe
- Advertisement -spot_img

Latest Articles